Epithelial Cell Culture Media Market Size & Share Report by 2028

The epithelial cell culture media market is expected to reach US$ 303,040.33 thousand by 2028 from US$ 128,155.95 thousand in 2020; it is estimated to grow at a CAGR of 11.4% from 2021 to 2028.

Epithelial cells are widespread throughout the body. These cells cover body surfaces, line body cavities, hollow organs, and major tissues in glands. These cells perform functions such as protection, absorption, secretion, excretion, diffusion, filtration, and sensory reception. These cells are widely used in disease modeling, toxicity studies, and drug discovery, among other applications. The growth of the epithelial cell culture media market is attributed to the factors such as the increasing applications of epithelial cells and surge in funding for epithelial cell research. However, the risk of contamination, misidentification, and random alternations in cell lines hinders the market growth.  

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Get 10% FREE CUSTOMIZATION

Epithelial Cell Culture Media Market: Strategic Insights

Epithelial Cell Culture Media Market

• 
  CAGR (2020 - 2028)

  11.4%
• Market Size 2020
  US$ 128.16 Million
• Market Size 2028
  US$ 303.04 Million

Market Dynamics

GROWTH DRIVERS

• XXXXXXX
• XXXXXXX
• XXXXXXX

FUTURE TRENDS

• XXXXXXX
• XXXXXXX
• XXXXXXX

OPPORTUNITIES

• XXXXXXX
• XXXXXXX
• XXXXXXX

Key Players

• PromoCell GmbH
• Merck KGaA
• ATCC
• AXOL Bioscience Ltd.
• Thermo Fisher Scientific Inc.
• Bio-Techne Corporation
• Celprogen Inc.
• Lonza Group AG
• HiMedia Laboratories

Regional Overview

• North America
• Europe
• Asia-Pacific
• South and Central America
• Middle East and Africa

Market Segmentation

Product Type

• Human Mammary Epithelial Cells
• Bronchia/Trachea Epithelial Cells
• Renal Epithelial Cells
• Others

End User

• Biopharmaceutical Companies
• Academic and Research Laboratories
• Others

Download Free Sample

   Buy Now   

• Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

Market Insights

Surge in Funding for Epithelial Cell Research

Extensive funding for supporting the research projects involving the use of epithelial cells to identify new therapeutic solutions for chronic diseases is propelling the demand for epithelial cell culture media. For instance, the National Institutes of Health (NIH), US, funded a 3-year research project (2013–2016) that was conducted at the University of Kentucky. The institute granted US$ 307,395 in funds in 2014 to examine processes controlling inflammation in colitis, a condition that stimulates epithelial stem cell growth and differentiation and increases the risk of colon cancer.

In 2018, scientists at the UCLA Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research along with those at the Stein Eye Institute were granted US$ 5.1 million by the California Institute for Regenerative Medicine to advance the development of a novel therapy for blinding retinal conditions. The project setup includes the use of patients’ own skin cells to generate autologous induced pluripotent stem cells to derive retinal pigment epithelium cells that are lost in blinding eye conditions.

Further, the Osaka University, Japan, conducted a research study—Observation of the Epithelial Cell Behavior in the Nasal Septum During Primary Palate Closure in Mice. This study was supported by Grants-In-Aid for Scientific Research Program of the Japan Society for the Promotion of Science. The increase in such grants for epithelial cell-based research projects are favoring the epithelial cells culture market growth.

Product Type-Based Insights

By product type, the epithelial cell culture media market is segmented into human mammary epithelial cells, bronchia/trachea epithelial cells, and renal epithelial cells. The bronchia/trachea epithelial cells segment held the largest share of the market in 2020, whereas the renal epithelial cell segment is anticipated to register the highest CAGR in the market during the forecast period.

End User-based Insights

Based on end user, the epithelial cell culture media treatment market is segmented into biopharmaceutical companies, academic and research laboratories, and others. The biopharmaceutical companies segment held the largest share of the market in 2020, whereas the academic and research laboratories segment is anticipated to register the highest CAGR of in the market during the forecast period.

 

Product launches and approvals are the commonly adopted strategies by companies to expand their global footprints and product portfolios. Moreover, the epithelial cell culture media market players focus on the collaboration strategy to enlarge their clientele, which, in turn, permits them to maintain their brand name globally.

Epithelial Cell Culture Media Market Report Scope

Download Free Sample

   Buy Now   

• Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

 

Epithelial Cell Culture Media Market – by Product Type

• Human Mammary Epithelial Cells
• Bronchia/Trachea Epithelial Cells
• Renal Epithelial Cells
• Others

Epithelial Cell Culture Media Market – by End User

• Biopharmaceutical Companies
• Academic and Research Laboratories
• Others

Epithelial Cell Culture Media Market – by Geography

• North America
  • US
  • Canada
  • Mexico
• Europe
  • France
  • Germany
  • Italy
  • UK
  • Spain
  • Rest of Europe
• Asia Pacific (APAC)
  • China
  • India
  • South Korea
  • Japan
  • Australia
  • Rest of Asia Pacific
• Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
• South and Central America (SCAM)
  • Brazil
  • Argentina
  • Rest of South and Central America

Company Profiles

• PromoCell GmbH
• Merck KGaA
• ATCC
• AXOL Bioscience Ltd.
• Thermo Fisher Scientific Inc.
• Bio-Techne Corporation
• Celprogen Inc.
• Lonza Group AG
• HiMedia Laboratories
• Cell Biologics Inc